ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,26%
Bitcoin
66.807,00
2,40%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Enliven Therapeutics Inc (ELVN)

  7. Enliven Therapeutics Inc (ELVN) News

ELVN Enliven Therapeutics Inc

23,04
-0,77 (-3,23%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:00:10
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Enliven Therapeutics Inc ELVN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,77 -3,23% 23,04 22:00:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
24,00 22,921 24,00 23,04 23,81
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.5.202401:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.5.202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.5.202422:10EDGAR2Form 8-K - Current report
14.5.202422:05GLOBEEnliven Therapeutics Reports First Quarter Financial Results..
14.5.202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.5.202402:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.5.202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.4.202413:55GLOBEEnliven Therapeutics Announces Positive Proof of Concept..
09.4.202422:05GLOBEEnliven Therapeutics Appoints Dr. Lori Kunkel to Board of..
28.3.202421:05GLOBEEnliven Therapeutics to Share Initial Proof of Concept Data..
19.3.202413:30GLOBEEnliven Therapeutics Announces $90 Million Private Placement..
14.3.202421:05GLOBEEnliven Therapeutics Reports Fourth Quarter and Full Year..
09.3.202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:43EDGAR2Form 144 - Report of proposed sale of securities
04.3.202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:05GLOBEEnliven Therapeutics to Present at TD Cowen’s 44th Annual..
27.2.202422:02EDGAR2Form 144 - Report of proposed sale of securities
21.2.202401:35EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
16.2.202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
16.2.202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202402:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202402:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202402:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202402:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202421:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.2.202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
01.2.202403:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202403:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202401:58EDGAR2Form 144 - Report of proposed sale of securities
25.1.202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202301:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202301:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202322:11EDGAR2Form 144 - Report of proposed sale of securities
22.12.202323:20EDGAR2Form 144 - Report of proposed sale of securities
22.12.202322:57EDGAR2Form 144 - Report of proposed sale of securities
21.12.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
ELVN
Enliven Therapeutics
COIN
KDCUSD
LSE
GDOB
AQSE
WHEA.GB
State Street Global Advi...
LSE
0ONY
Tecnotree Oyj
BOV
VALEL765
VALEL765 Ex:73,83
TSX
HUTL
Harvest Equal Weight Glo...
BIT
F17099
Vontobel Financial Produ...
LSE
ECSC
Ecsc
USOTC
RBSFY
Rubis (PK)
LSE
0REP
Constellation Brands
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten